Development of a hybrid artificial intelligence framework for pharmacotherapy optimization.
The proposed framework conceptualizes AI as a relevance-structuring, clinician-governed decision-support layer rather than an autonomous decision-maker rather than an autonomous decision-maker and provides a conceptual foundation for future development, implementation, and evaluation of AI-supported pharmacotherapy systems.